Circulating SARS-CoV-2 spike N439K variants maintain fitness while evading antibody-mediated immunity (Q108396862)

scientific article

Language	Label	Description	Also known as
English	Circulating SARS-CoV-2 spike N439K variants maintain fitness while evading antibody-mediated immunity	scientific article

Statements

instance of

scholarly article

0 references

title

Circulating SARS-CoV-2 spike N439K variants maintain fitness while evading antibody-mediated immunity (English)

0 references

1 reference

David J Pascall

9

0 references

Daniel Mair

object named as

Daniel Mair

series ordinal

43

0 references

Laura E Rosen

object named as

Laura E Rosen

series ordinal

2

0 references

Arthur Wickenhagen

object named as

Arthur Wickenhagen

series ordinal

40

0 references

Rajiv Shah

object named as

Rajiv Shah

series ordinal

13

0 references

Rachel Norris

object named as

Rachel M Colquhoun

series ordinal

21

0 references

Marco Schiuma

object named as

Marco Schiuma

series ordinal

54

0 references

Luca Piccoli

object named as

Luca Piccoli

series ordinal

8

0 references

James G Shepherd

object named as

James G Shepherd

series ordinal

3

0 references

Suzannah J Rihn

object named as

Suzannah J Rihn

series ordinal

62

0 references

Antonia Ho

object named as

Antonia Ho

series ordinal

53

0 references

Katherine Smollett

object named as

Katherine Smollett

series ordinal

45

0 references

Roberto Spreafico

object named as

Roberto Spreafico

series ordinal

4

0 references

Natasha Palmalux

object named as

Natasha Johnson

series ordinal

38

0 references

Christopher A Davis

object named as

Chris Davis

series ordinal

7

0 references

Alessandro Ceschi

object named as

Alessandro Ceschi

series ordinal

41

0 references

Ruth F. Jarrett

object named as

Ruth F Jarrett

series ordinal

30

0 references

Kyriaki Nomikou

object named as

Kyriaki Nomikou

series ordinal

33

0 references

Malcolm G. Semple

object named as

Malcolm G Semple

series ordinal

55

0 references

Emma C Thomson

object named as

Emma C Thomson

series ordinal

1

0 references

Paolo Ferrari

object named as

Paolo Ferrari

series ordinal

44

0 references

Peter Openshaw

series ordinal

56

object named as

Peter J M Openshaw

0 references

Spyros Lytras

series ordinal

11

object named as

Spyros Lytras

0 references

Nadine Czudnochowski

series ordinal

12

object named as

Nadine Czudnochowski

0 references

Aoife M Harbison

object named as

Aoife M Harbison

series ordinal

42

0 references

Jenna Nichols

object named as

Jenna Nichols

series ordinal

49

0 references

Andrew Rambaut

object named as

Andrew Rambaut

series ordinal

25

0 references

Tristan I. Croll

object named as

Tristan I Croll

series ordinal

37

0 references

Joseph Hughes

object named as

Joseph Hughes

series ordinal

51

0 references

Federica Sallusto

object named as

Federica Sallusto

series ordinal

46

0 references

Lily Tong

series ordinal

35

object named as

Lily Tong

0 references

author name string

Ana da Silva Filipe

series ordinal

5

0 references

Jason A Wojcechowskyj

series ordinal

6

0 references

Josh Dillen

series ordinal

10

0 references

Marcel Meury

series ordinal

14

0 references

Natasha Jesudason

series ordinal

15

0 references

Anna De Marco

series ordinal

16

0 references

Kathy Li

series ordinal

17

0 references

Jessica Bassi

series ordinal

18

0 references

Aine O'Toole

series ordinal

19

0 references

Dora Pinto

series ordinal

20

0 references

Katja Culap

series ordinal

22

0 references

Ben Jackson

series ordinal

23

0 references

Fabrizia Zatta

series ordinal

24

0 references

Stefano Jaconi

series ordinal

26

0 references

Vattipally B Sreenu

series ordinal

27

0 references

Jay Nix

series ordinal

28

0 references

Ivy Zhang

series ordinal

29

0 references

William G Glass

series ordinal

31

0 references

Martina Beltramello

series ordinal

32

0 references

Matteo Pizzuto

series ordinal

34

0 references

Elisabetta Cameroni

series ordinal

36

0 references

Julia Di Iulio

series ordinal

39

0 references

Stephen Carmichael

series ordinal

47

0 references

Christian Garzoni

series ordinal

48

0 references

Massimo Galli

series ordinal

50

0 references

Agostino Riva

series ordinal

52

0 references

Elisa Fadda

series ordinal

57

0 references

J Kenneth Baillie

series ordinal

58

0 references

John D Chodera

series ordinal

59

0 references

Samantha J Lycett

series ordinal

63

0 references

Herbert W Virgin

series ordinal

64

0 references

Amalio Telenti

series ordinal

65

0 references

Davide Corti

series ordinal

66

0 references

David L Robertson

series ordinal

67

0 references

Gyorgy Snell

series ordinal

68

0 references

language of work or name

English

0 references

publication date

4 March 2021

0 references

published in

Cell

0 references

volume

184

0 references

issue

5

0 references

page(s)

1171-1187.e20

0 references

describes a project that uses

1 reference

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7843029/

PyMOL

1 reference

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pmc&rettype=xml&id=PMC7843029

cites work

Structural and Functional Analysis of the D614G SARS-CoV-2 Spike Protein Variant

1 reference

stated in

COCI

reference URL

https://opencitations.net/index/coci/api/v1/citations/10.1016/J.CELL.2020.09.032

retrieved

30 October 2021

MDTraj: A Modern Open Library for the Analysis of Molecular Dynamics Trajectories.

2 references

19 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1016/J.BPJ.2015.08.015

19 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CELL.2021.01.037

Phasercrystallographic software

1 reference

19 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CELL.2021.01.037

MDAnalysis: a toolkit for the analysis of molecular dynamics simulations

1 reference

19 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CELL.2021.01.037

Deep mutational scanning of SARS-CoV-2 receptor binding domain reveals constraints on folding and ACE2 binding

1 reference

19 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CELL.2021.01.037

IQ-TREE 2: New models and efficient methods for phylogenetic inference in the genomic era

1 reference

19 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CELL.2021.01.037

Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor

1 reference

19 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CELL.2021.01.037

A Haploid Genetic Screen Identifies Heparan Sulfate Proteoglycans Supporting Rift Valley Fever Virus Infection

1 reference

19 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CELL.2021.01.037

Comprehensive characterization of N- and O- glycosylation of SARS-CoV-2 human receptor angiotensin converting enzyme 2

1 reference

19 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CELL.2021.01.037

Rapid implementation of SARS-CoV-2 sequencing to investigate cases of health-care associated COVID-19: a prospective genomic surveillance study

1 reference

19 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CELL.2021.01.037

Structural basis of receptor recognition by SARS-CoV-2

1 reference

19 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CELL.2021.01.037

Evolution of antibody immunity to SARS-CoV-2

1 reference

19 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CELL.2021.01.037

SARS-CoV-2 spike-protein D614G mutation increases virion spike density and infectivity

1 reference

19 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CELL.2021.01.037

Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial

1 reference

19 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CELL.2021.01.037

Coronavirus RNA Proofreading: Molecular Basis and Therapeutic Targeting

1 reference

19 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CELL.2021.01.037

Tracking changes in SARS-CoV-2 Spike: evidence that D614G increases infectivity of the COVID-19 virus

1 reference

19 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CELL.2021.01.037

Structure of SARS coronavirus spike receptor-binding domain complexed with receptor

1 reference

19 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CELL.2021.01.037

Structural Basis for Potent Neutralization of Betacoronaviruses by Single-Domain Camelid Antibodies

1 reference

19 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CELL.2021.01.037

The Impact of Mutations in SARS-CoV-2 Spike on Viral Infectivity and Antigenicity

1 reference

19 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CELL.2021.01.037

An amplicon-based sequencing framework for accurately measuring intrahost virus diversity using PrimalSeq and iVar

1 reference

19 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CELL.2021.01.037

ape 5.0: an environment for modern phylogenetics and evolutionary analyses in R

1 reference

19 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CELL.2021.01.037

A SARS-CoV-2 vaccine candidate would likely match all currently circulating variants

1 reference

19 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CELL.2021.01.037

Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model

1 reference

19 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CELL.2021.01.037

A new coronavirus associated with human respiratory disease in China

1 reference

19 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CELL.2021.01.037

Antibody cocktail to SARS-CoV-2 spike protein prevents rapid mutational escape seen with individual antibodies

1 reference

19 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CELL.2021.01.037

GLYCAM06: a generalizable biomolecular force field. Carbohydrates

1 reference

19 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CELL.2021.01.037

UCSF ChimeraX: Structure Visualization for Researchers, Educators, and Developers

1 reference

19 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CELL.2021.01.037

Ultrapotent human antibodies protect against SARS-CoV-2 challenge via multiple mechanisms

1 reference

19 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CELL.2021.01.037

Features and development of Coot

1 reference

19 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CELL.2021.01.037

MDAnalysis: A Python Package for the Rapid Analysis of Molecular Dynamics Simulations

1 reference

19 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CELL.2021.01.037

Minimap2: pairwise alignment for nucleotide sequences

1 reference

19 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CELL.2021.01.037

Evaluating the Effects of SARS-CoV-2 Spike Mutation D614G on Transmissibility and Pathogenicity

1 reference

19 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CELL.2021.01.037

Genomic epidemiology reveals multiple introductions of SARS-CoV-2 from mainland Europe into Scotland

1 reference

19 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CELL.2021.01.037

Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation

1 reference

19 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CELL.2021.01.037

Evolutionary origins of the SARS-CoV-2 sarbecovirus lineage responsible for the COVID-19 pandemic

1 reference

19 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CELL.2021.01.037

Neutralizing Antibodies against SARS-CoV-2 and Other Human Coronaviruses

1 reference

19 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CELL.2021.01.037

A system for functional analysis of Ebola virus glycoprotein

1 reference

19 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CELL.2021.01.037

Site-specific glycan analysis of the SARS-CoV-2 spike

1 reference

19 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CELL.2021.01.037

IPython: A System for Interactive Scientific Computing

1 reference

19 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CELL.2021.01.037

Sequence-to-structure dependence of isolated IgG Fc complex biantennary N-glycans: A molecular dynamics study

1 reference

19 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CELL.2021.01.037

An integrated national scale SARS-CoV-2 genomic surveillance network

1 reference

19 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CELL.2021.01.037

COMPUTING: Screen Savers of the World Unite!

1 reference

19 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CELL.2021.01.037

Persistence and Evolution of SARS-CoV-2 in an Immunocompromised Host

1 reference

19 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CELL.2021.01.037

A clade of SARS-CoV-2 viruses associated with lower viral loads in patient upper airways

1 reference

19 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CELL.2021.01.037

REFMAC5 for the refinement of macromolecular crystal structures

1 reference

19 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CELL.2021.01.037

Convergent antibody responses to SARS-CoV-2 in convalescent individuals

1 reference

19 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CELL.2021.01.037

Suptavumab for the Prevention of Medically Attended Respiratory Syncytial Virus Infection in Preterm Infants

1 reference

19 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CELL.2021.01.037

Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein

1 reference

19 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CELL.2021.01.037

The influenza virus hemagglutinin head evolves faster than the stalk domain

1 reference

19 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CELL.2021.01.037

Studies in humanized mice and convalescent humans yield a SARS-CoV-2 antibody cocktail

1 reference

19 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CELL.2021.01.037

SARS-CoV-2 Neutralizing Antibody LY-CoV555 in Outpatients with Covid-19

1 reference

19 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CELL.2021.01.037

Virus-Receptor Interactions of Glycosylated SARS-CoV-2 Spike and Human ACE2 Receptor

1 reference

19 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CELL.2021.01.037

Scalable relaxed clock phylogenetic dating

1 reference

19 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CELL.2021.01.037

Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody

1 reference

19 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CELL.2021.01.037

The SARS-CoV-2 Spike protein has a broad tropism for mammalian ACE2 proteins

1 reference

19 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CELL.2021.01.037

D614G Spike Mutation Increases SARS CoV-2 Susceptibility to Neutralization

1 reference

19 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CELL.2021.01.037

Fast and accurate short read alignment with Burrows-Wheeler transform

1 reference

19 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CELL.2021.01.037

ff14SB: Improving the Accuracy of Protein Side Chain and Backbone Parameters from ff99SB.

1 reference

19 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CELL.2021.01.037

Comparison of simple potential functions for simulating liquid water

1 reference

19 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CELL.2021.01.037

Broad neutralization of SARS-related viruses by human monoclonal antibodies

1 reference

19 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CELL.2021.01.037

1 reference

19 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CELL.2021.01.037

Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants

1 reference

19 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CELL.2021.01.037

pdb-tools: a swiss army knife for molecular structures

1 reference

19 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CELL.2021.01.037

How single mutations affect viral escape from broad and narrow antibodies to H1 influenza hemagglutinin.

1 reference

19 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CELL.2021.01.037

Transmission dynamics and evolutionary history of 2019-nCoV

1 reference

19 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CELL.2021.01.037

Emergence of SARS-CoV-2 through recombination and strong purifying selection

1 reference

19 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CELL.2021.01.037

Mapping Neutralizing and Immunodominant Sites on the SARS-CoV-2 Spike Receptor-Binding Domain by Structure-Guided High-Resolution Serology

1 reference

19 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CELL.2021.01.037

A neutralizing antibody selected from plasma cells that binds to group 1 and group 2 influenza A hemagglutinins

1 reference

19 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CELL.2021.01.037

Phase 1-2 Trial of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine

1 reference

19 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CELL.2021.01.037

Transmission of SARS-CoV-2 on mink farms between humans and mink and back to humans

1 reference

19 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CELL.2021.01.037

Retroviral vectors pseudotyped with severe acute respiratory syndrome coronavirus S protein

1 reference

19 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CELL.2021.01.037

Systematic Parameterization of Monovalent Ions Employing the Nonbonded Model

1 reference

19 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CELL.2021.01.037

A dynamic nomenclature proposal for SARS-CoV-2 lineages to assist genomic epidemiology

1 reference

19 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CELL.2021.01.037

Robust and efficient configurational molecular sampling via Langevin dynamics.

1 reference

19 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CELL.2021.01.037

Recurrent deletions in the SARS-CoV-2 spike glycoprotein drive antibody escape

1 reference

19 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CELL.2021.01.037

OpenMM 7: Rapid development of high performance algorithms for molecular dynamics.

1 reference

19 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CELL.2021.01.037

Beyond Shielding: The Roles of Glycans in the SARS-CoV-2 Spike Protein

1 reference

19 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CELL.2021.01.037

ISOLDE: a physically realistic environment for model building into low-resolution electron-density maps

1 reference

19 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CELL.2021.01.037

Substantial underestimation of SARS-CoV-2 infection in the United States

1 reference

19 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CELL.2021.01.037

An mRNA Vaccine against SARS-CoV-2 - Preliminary Report

1 reference

19 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CELL.2021.01.037

Identifiers

DOI

10.1016/J.CELL.2021.01.037

0 references

0 references

0 references

Circulating SARS-CoV-2 spike N439K variants maintain fitness while evading antibody-mediated immunity (Q108396862)

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Navigation menu

Circulating SARS-CoV-2 spike N439K variants maintain fitness while evading antibody-mediated immunity (Q108396862)

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Navigation menu

Search